ticlopidine has been researched along with Carotid Stenosis in 106 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
Carotid Stenosis: Narrowing or stricture of any part of the CAROTID ARTERIES, most often due to atherosclerotic plaque formation. Ulcerations may form in atherosclerotic plaques and induce THROMBUS formation. Platelet or cholesterol emboli may arise from stenotic carotid lesions and induce a TRANSIENT ISCHEMIC ATTACK; CEREBROVASCULAR ACCIDENT; or temporary blindness (AMAUROSIS FUGAX). (From Adams et al., Principles of Neurology, 6th ed, pp 822-3)
| Excerpt | Relevance | Reference |
|---|---|---|
| " We investigated the effects of cilostazol 200 mg, in addition to aspirin 100 mg and clopidogrel 75 mg, on carotid intima-media thickness (IMT) progression during a 2-year follow-up period in patients with acute coronary syndrome (ACS) requiring stent implantation." | 9.15 | Cilostazol reduces the progression of carotid intima-media thickness without increasing the risk of bleeding in patients with acute coronary syndrome during a 2-year follow-up. ( Ahn, CM; Hong, SJ; Kim, JS; Lim, DS; Park, JH, 2011) |
| "Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) is a randomized, double-blind study in subjects with recently symptomatic > or =50% carotid stenosis." | 9.11 | Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial. ( Droste, DW; Kaps, M; Larrue, V; Lees, KR; Markus, HS; Ringelstein, EB; Siebler, M, 2005) |
| " Diabetes mellitus and current smoker status were independent factors related to reactivity to clopidogrel." | 7.83 | Influence of Diabetes Mellitus and Cigarette Smoking on Variability of the Clopidogrel-Induced Antiplatelet Effect and Efficacy of Active Management of the Target P2Y12 Reaction Unit Range in Patients Undergoing Neurointerventional Procedures. ( Hironaka, Y; Kichikawa, K; Motoyama, Y; Nakagawa, I; Nakase, H; Park, HS; Takayama, K; Wada, T; Yokoyama, S, 2016) |
| "The CARESS (Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic carotid Stenosis) trial proved the effectiveness of the combination of clopidogrel and aspirin compared with aspirin alone in reducing presence and number of microembolic signals (MES) in patients with recently symptomatic carotid stenosis." | 7.73 | The use of embolic signal detection in multicenter trials to evaluate antiplatelet efficacy: signal analysis and quality control mechanisms in the CARESS (Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic carotid Stenosis) trial. ( Dittrich, R; Droste, DW; Kaps, M; Larrue, V; Lees, K; Markus, HS; Nabavi, DG; Ringelstein, EB; Ritter, MA; Siebler, M, 2006) |
| "Clopidogrel has a favourable side effect profile, in which the most serious complications are related to bleeding diathesis." | 5.34 | Noncardiogenic pulmonary edema associated with clopidogrel: a serious but unexpected side effect of clopidogrel. ( Akyol, A; Eksik, A; Erdinler, IC; Ucer, E; Yazici, S, 2007) |
| " In a previous study, we found that the number of MESs is associated with stroke recurrence and that clopidogrel plus aspirin more effectively reduce the number of MESs than does aspirin alone." | 5.22 | The curative effect comparison of two kinds of therapeutic regimens on decreasing the relative intensity of microembolic signal in CLAIR trial. ( Chen, C; Deng, QQ; Fu, JH; Huang, YN; Markus, H; Ratanakorn, D; Tang, J; Wong, KS; Zhao, H, 2016) |
| " Patients with Helicobacter pylori infection and a history of peptic ulcer were assigned dual antiplatelet combination with omeprazole." | 5.17 | Effect of clopidogrel with or without omeprazole in patients with carotid artery stenting. ( Chen, G; Du, Y; Hang, L; Ma, B, 2013) |
| " We investigated the effects of cilostazol 200 mg, in addition to aspirin 100 mg and clopidogrel 75 mg, on carotid intima-media thickness (IMT) progression during a 2-year follow-up period in patients with acute coronary syndrome (ACS) requiring stent implantation." | 5.15 | Cilostazol reduces the progression of carotid intima-media thickness without increasing the risk of bleeding in patients with acute coronary syndrome during a 2-year follow-up. ( Ahn, CM; Hong, SJ; Kim, JS; Lim, DS; Park, JH, 2011) |
| "The clopidogrel plus aspirin for infarction reduction in acute stroke or transient ischaemic attack patients with large artery stenosis and microembolic signals (CLAIR) trial was a randomised, open-label, blinded-endpoint trial." | 5.14 | Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial. ( Chang, HM; Chen, C; Chollate, P; Fu, J; Han, Z; Hao, Q; Huang, YN; Koh, A; Markus, HS; Ratanakorn, D; Suwanwela, NC; Tan, KS; Wong, KS; Zhao, Y, 2010) |
| "Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) is a randomized, double-blind study in subjects with recently symptomatic > or =50% carotid stenosis." | 5.11 | Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial. ( Droste, DW; Kaps, M; Larrue, V; Lees, KR; Markus, HS; Ringelstein, EB; Siebler, M, 2005) |
| "Drugs that prevent platelets from sticking together-ie, aspirin, dipyridamole, and clopidogrel-are an important part of therapy to prevent recurrence of ischemic stroke of atherosclerotic origin." | 4.89 | Antiplatelet therapy to prevent recurrent stroke: Three good options. ( Mansoor, AH; Mujtaba, MT; Silver, B, 2013) |
| " Currently, aspirin is generally prescribed for the primary prevention of stroke despite a number of trial results on effectiveness proving inconclusive." | 4.85 | Antithrombotic therapies in cerebrovascular disease: what should we use as secondary prevention in patients with carotid artery disease? ( Beckman, JA, 2009) |
| " Diabetes mellitus and current smoker status were independent factors related to reactivity to clopidogrel." | 3.83 | Influence of Diabetes Mellitus and Cigarette Smoking on Variability of the Clopidogrel-Induced Antiplatelet Effect and Efficacy of Active Management of the Target P2Y12 Reaction Unit Range in Patients Undergoing Neurointerventional Procedures. ( Hironaka, Y; Kichikawa, K; Motoyama, Y; Nakagawa, I; Nakase, H; Park, HS; Takayama, K; Wada, T; Yokoyama, S, 2016) |
| "Data obtained in this study suggest a suboptimal clopidogrel response in patients with greater body weight and body mass index." | 3.77 | Body weight: a risk factor for subtherapeutic antithrombotic therapy in neurovascular stenting. ( Alexander, MJ; Choulakian, A; Drazin, D; Kornbluth, P; Nuño, M, 2011) |
| "The CARESS (Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic carotid Stenosis) trial proved the effectiveness of the combination of clopidogrel and aspirin compared with aspirin alone in reducing presence and number of microembolic signals (MES) in patients with recently symptomatic carotid stenosis." | 3.73 | The use of embolic signal detection in multicenter trials to evaluate antiplatelet efficacy: signal analysis and quality control mechanisms in the CARESS (Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic carotid Stenosis) trial. ( Dittrich, R; Droste, DW; Kaps, M; Larrue, V; Lees, K; Markus, HS; Nabavi, DG; Ringelstein, EB; Ritter, MA; Siebler, M, 2006) |
| "(1) Aspirin reduces the risk of myocardial infarction in men over 40 with no history of cardiovascular disease, and in hypertensive patients of both sexes over that age." | 3.70 | Antiplatelet drugs in cardiovascular prevention: coronary events and stroke: primary prevention. ( , 2000) |
| "Strokes are infrequent but potentially serious complications following carotid intervention, but antiplatelet therapy can reduce these risks." | 2.82 | Antiplatelet Therapy in Carotid Artery Stenting and Carotid Endarterectomy in the Asymptomatic Carotid Surgery Trial-2. ( Bulbulia, R; Coppi, G; de Borst, GJ; Halliday, A; Huibers, A, 2016) |
| "In one patient a transient ischemic attack occurred." | 2.78 | High versus standard clopidogrel loading in patients undergoing carotid artery stenting prior to cardiac surgery to assess the number of microemboli detected with transcranial Doppler: results of the randomized IMPACT trial. ( Ackerstaff, RG; Breet, NJ; De Vries, JP; Deneer, VH; Elsenberg, EH; Hackeng, CM; Kelder, JC; Schonewille, WJ; Suttorp, MJ; Ten Berg, JM; Tromp, SC; Van Der Heyden, J; Van Neerven, D; Van Werkum, J; Vos, JA; Wolters, F, 2013) |
| "To investigate the effect of removing phlegm and dispelling stasis method (RPDSM) combined with Western medicine for treatment of cerebrovascular stenosis." | 2.73 | [Removing phlegm and dispelling stasis method combined with Western medicine for treatment of cerebrovascular stenosis]. ( Gao, L; Liu, Q; Wang, PP, 2008) |
| " Twenty-six patients were dosed for 2 weeks, 300 mg aspirin once daily and then for 2 weeks, 250 mg ticlopidine twice daily." | 2.68 | Asymptomatic circulating cerebral emboli and cerebral blood flow velocity under aspirin and ticlopidine in patients with cerebrovascular disease. ( Droste, DW; Kaps, M; Siemens, HJ; Sonne, M, 1996) |
| "The diagnosis of carotid stenosis is made after occurrence of a cerebral ischemic event or during an angiologic examination, mainly using Doppler/Duplex-sonography." | 2.42 | [Carotid stenosis: diagnosis, patient selection, therapy]. ( Barth, A, 2003) |
| "Strokes due to carotid artery stenosis differ in outcome from those due to cardiac embolism; the most benign group is that of lacunar strokes." | 2.38 | Outcome of transient ischaemic attacks and stroke. ( Norris, JW, 1991) |
| "All the patients presented with carotid artery stenosis >70% (North American Symptomatic Carotid Endarterectomy Trial [NASCET] criteria), which was symptomatic in 42 patients (transient ischemic attack, n = 32; minor stroke, n = 10) and asymptomatic in 146." | 1.46 | Dual Antiplatelet Therapy Does Not Increase the Risk of Bleeding After Carotid Endarterectomy: Results of a Prospective Study. ( Calio', FG; Illuminati, G; Masci, F; Pizzardi, G; Ricco, JB; Schneider, F, 2017) |
| " We took into consideration adverse events including death from any cause, major stroke within 30 days, and death between 30 days and 1 year later from any stroke." | 1.46 | The Feasibility and Safety of Separate Carotid Artery Stenting Using the Restrict Protective Method for Bilateral Carotid Stenosis. ( Bishnori, I; Goto, S; Ishikawa, K; Kato, Y; Ohshima, T; Yamamoto, T, 2017) |
| " The purpose of this study was to compare the efficacy and safety of clopidogrel combined with aspirin (CA) versus sarpogrelate combined with aspirin (SA) treatment in carotid endarterectomy (CEA) patients." | 1.43 | Effects of Sarpogrelate Combined with Aspirin in Patients Undergoing Carotid Endarterectomy in China: A Single-Center Retrospective Study. ( Gu, Y; Guo, J; Guo, L; Qi, L; Tong, Z; Wang, Z; Yu, H; Zhang, J, 2016) |
| "The early recurrence of neurological symptoms (NR) after urgent aggressive best medical therapy (BMT) in symptomatic carotid stenosis is not well documented." | 1.43 | Risk of early recurrent stroke in symptomatic carotid stenosis after best medical therapy and before endarterectomy. ( Ellemann, K; Gottschalksen, B; Owen-Falkenberg, A; Shahidi, S, 2016) |
| " Long-term use of aspirin plus clopidorel after CAS did not decrease the risk of ischemic stroke, composite vascular events, or death during 6 months of follow-up." | 1.42 | Is Extended Duration of Dual Antiplatelet Therapy After Carotid Stenting Beneficial? ( Huang, JY; Jhang, KM; Jian, ZH; Ku, WY; Liaw, YP; Nfor, ON; Tung, YC, 2015) |
| "A total of 949 patients with cervical carotid artery stenosis were enrolled at 43 institutions in Japan; 934 who had undergone CAS with antiplatelet drugs and followed for 1 year were analyzed." | 1.40 | Prospective registry of carotid artery stenting in Japan--investigation on device and antiplatelet for carotid artery stenting. ( Ezura, M; Hyodo, A; Matsubara, Y; Matsumaru, Y; Matsumoto, Y; Miyachi, S; Nakamura, M; Okada, Y; Sakai, C; Sakai, N; Terada, T; Yamagami, H; Yokoi, H, 2014) |
| "Of a total of 4905 (transient ischemic attack/ischemic stroke, and ocular events) patients, 115 symptomatic patients underwent CEA, 42% within 14 days of the index event and 99% within 14 days of surgical referral." | 1.39 | Urgent best medical therapy may obviate the need for urgent surgery in patients with symptomatic carotid stenosis. ( Ellemann, K; Hjerpsted, U; Owen-Falkenberg, A; Rai, A; Shahidi, S, 2013) |
| "In the Asymptomatic Carotid Artery Stenosis trial (1995), medical management was defined as aspirin in addition to adequate control of comorbidities." | 1.39 | Efficacy of contemporary medical management for asymptomatic carotid artery stenosis. ( Ahn, JE; Chang, J; Chun, L; Landsman, N; Patel, KK; Rhee, K, 2013) |
| "The fourth patient developed critical stenosis distal to the aneurysm neck." | 1.39 | Continued concern about parent vessel steno-occlusive progression with Onyx HD-500 and the utility of quantitative magnetic resonance imaging in serial assessment. ( Alaraj, A; Aletich, VA; Amin-Hanjani, S; Carlson, AP; Charbel, FT, 2013) |
| "Cerebral infarction associated with ulcerative colitis is particularly rare, but clinically important because of its high morbidity and mortality." | 1.37 | Recurrent ischemic stroke in a patient with ulcerative colitis and high levels of lipoprotein (a). ( Bramanti, P; Calabrò, RS; Gervasi, G; Pezzini, A; Pollicino, P, 2011) |
| "Intimal hyperplasia is a major cause of restenosis after the interventional or surgical treatment of occlusive arterial disease." | 1.35 | Reduced intimal hyperplasia in rabbits via medical therapy after carotid venous bypass. ( Bahcivan, M; Erenler, BH; Gol, MK; Keceligil, HT; Kolbakir, F; Yucel, S, 2009) |
| "A 70-year-old male patient with 90% stenosis of the right carotid artery and total occlusion of the left carotid artery underwent right carotid stenting." | 1.34 | Carotid artery in-stent restenosis in a patient with contralateral total occlusion, resolved with drug-eluting stenting. ( Iancu, A; Lazar, A, 2007) |
| "Clopidogrel has a favourable side effect profile, in which the most serious complications are related to bleeding diathesis." | 1.34 | Noncardiogenic pulmonary edema associated with clopidogrel: a serious but unexpected side effect of clopidogrel. ( Akyol, A; Eksik, A; Erdinler, IC; Ucer, E; Yazici, S, 2007) |
| "Acute in-stent thrombosis is a well-known complication of carotid angioplasty and stenting (CAS) and often due to resistance to or inadequate treatment with platelet-inhibiting agents." | 1.33 | Late in-stent thrombosis following carotid angioplasty and stenting. ( Buhk, JH; Knauth, M; Wellmer, A, 2006) |
| "To report procedure-related complications and neurological adverse events of unprotected over-the-wire (OTW) and protected rapid exchange (RX) carotid artery stenting (CAS) in a single-center patient series during an 8-year period." | 1.33 | Procedure-related complications and early neurological adverse events of unprotected and protected carotid stenting: temporal trends in a consecutive patient series. ( Ahmadi, A; Amighi, J; Boltuch, J; Dick, P; Minar, E; Mlekusch, W; Sabeti, S; Schillinger, M; Schlager, O, 2005) |
| "A plaque embolism was excluded clinically and in the contrast-medium intensified MRT 5 days after the intervention in 79/81 (97." | 1.32 | [Outpatient primary stent-angioplasty in symptomatic internal carotid artery stenoses]. ( Andresen, R; Brinckmann, W; Roth, M, 2003) |
| " Closure of the femoral access site after carotid stenting using a Perclose closure device is safe and effective even in patients receiving an aggressive anticoagulation and antiplatelet therapy." | 1.32 | Safety and efficacy of the Perclose suture-mediated closure device following carotid artery stenting under clopidogrel platelet blockade. ( Borisch, I; Feuerbach, S; Finkenzeller, T; Hamer, O; Lenhart, M; Link, J; Paetzel, C; Toepel, I; Zorger, N, 2004) |
| "We describe a man who developed aplastic anaemia after 5 months of treatment with clopidogrel." | 1.31 | Fatal aplastic anaemia associated with clopidogrel. ( Cambier, N; Caron, J; Mahieu, M; Rose, C; Trivier, JM, 2001) |
| " We present several illustrative cases in which platelet monitoring with the Rapid Platelet Function Assay (RPFA, Accumetrics) was used to guide dosing of a glycoprotein (GP) IIb/IIIa inhibitor for coronary and peripheral intervention among patients at increased bleeding risk." | 1.31 | Clinical application of procedural platelet monitoring during percutaneous coronary intervention among patients at increased bleeding risk. ( Chew, DP; Moliterno, DJ; Mukherjee, D; Raymond, RE; Robbins, M; Yadav, JS, 2001) |
| "We present a case of internal carotid artery stenosis with a complaint of transient mono-ocular blindedness, whose ischaemic attack was relieved by PTA operation." | 1.29 | Percutaneous transluminal angioplasty of internal carotid artery: a preliminary report of seesaw balloon technique. ( Itoh, M; Kinoshita, A; Takemoto, O, 1993) |
| "Most of cerebral infarctions were observed in the hemisphere, ipsilateral to the irradiated carotid artery." | 1.29 | Effect of Y-20811, a thromboxane synthetase inhibitor, on photochemically induced cerebral embolism in rabbits. ( Fujimura, M; Mikashima, H, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (6.60) | 18.2507 |
| 2000's | 46 (43.40) | 29.6817 |
| 2010's | 50 (47.17) | 24.3611 |
| 2020's | 3 (2.83) | 2.80 |
| Authors | Studies |
|---|---|
| Simonte, G | 1 |
| Guglielmini, G | 1 |
| Falcinelli, E | 1 |
| Isernia, G | 1 |
| Mezzasoma, AM | 1 |
| Gresele, P | 1 |
| Lenti, M | 1 |
| Muram, S | 1 |
| Panchendrabose, K | 1 |
| Eagles, ME | 1 |
| Salam, MSA | 1 |
| Eesa, M | 1 |
| Agbani, EO | 1 |
| Hill, MD | 1 |
| Riva-Cambrin, J | 1 |
| Mitha, AP | 1 |
| Manunga, J | 1 |
| Pedersen, C | 1 |
| Stanberry, L | 1 |
| Pai, A | 1 |
| Skeik, N | 1 |
| Sullivan, TM | 1 |
| Ohshima, T | 1 |
| Bishnori, I | 1 |
| Ishikawa, K | 1 |
| Goto, S | 1 |
| Yamamoto, T | 1 |
| Kato, Y | 1 |
| Kinsella, JA | 1 |
| Oliver Tobin, W | 1 |
| Tierney, S | 1 |
| Feeley, TM | 1 |
| Egan, B | 1 |
| Coughlan, T | 1 |
| Ronan Collins, D | 1 |
| O'Neill, D | 1 |
| Harbison, JA | 1 |
| Doherty, CP | 1 |
| Madhavan, P | 1 |
| Moore, DJ | 1 |
| O'Neill, SM | 1 |
| Colgan, MP | 1 |
| Saqqur, M | 1 |
| Murphy, RP | 1 |
| Moran, N | 1 |
| Hamilton, G | 1 |
| McCabe, DJH | 1 |
| Bissacco, D | 1 |
| Carmo, M | 1 |
| Barbetta, I | 1 |
| Dallatana, R | 1 |
| Settembrini, PG | 1 |
| Graham, BR | 1 |
| Menon, BK | 1 |
| Mistry, EA | 1 |
| Khoury, JC | 1 |
| Kleindorfer, D | 1 |
| Patti, G | 1 |
| Tomai, F | 1 |
| Melfi, R | 1 |
| Ricottini, E | 1 |
| Macrì, M | 1 |
| Sedati, P | 1 |
| Giardina, A | 1 |
| Aurigemma, C | 1 |
| Leporace, M | 1 |
| D'Ambrosio, A | 1 |
| Di Sciascio, G | 1 |
| Tsutsumi, M | 2 |
| Aikawa, H | 2 |
| Nii, K | 2 |
| Etou, H | 1 |
| Sakamoto, K | 1 |
| Kureshima, M | 1 |
| Inoue, R | 1 |
| Yoshida, H | 1 |
| Matsumoto, Y | 2 |
| Narita, S | 1 |
| Kazekawa, K | 2 |
| Shahidi, S | 2 |
| Owen-Falkenberg, A | 2 |
| Hjerpsted, U | 1 |
| Rai, A | 1 |
| Ellemann, K | 2 |
| Sorkin, GC | 1 |
| Dumont, TM | 1 |
| Wach, MM | 1 |
| Eller, JL | 1 |
| Mokin, M | 1 |
| Natarajan, SK | 1 |
| Baxter, MS | 1 |
| Snyder, KV | 1 |
| Levy, EI | 2 |
| Hopkins, LN | 1 |
| Siddiqui, AH | 1 |
| Turan, TN | 3 |
| Smock, A | 1 |
| Chimowitz, MI | 3 |
| Chang, J | 1 |
| Ahn, JE | 1 |
| Landsman, N | 1 |
| Rhee, K | 1 |
| Chun, L | 1 |
| Patel, KK | 1 |
| Derdeyn, CP | 2 |
| Lynn, MJ | 2 |
| Fiorella, D | 2 |
| Janis, LS | 2 |
| Montgomery, J | 2 |
| Nizam, A | 1 |
| Lane, BF | 2 |
| Lutsep, HL | 2 |
| Barnwell, SL | 1 |
| Waters, MF | 1 |
| Hoh, BL | 1 |
| Hourihane, JM | 1 |
| Alexandrov, AV | 2 |
| Harrigan, MR | 1 |
| Chiu, D | 1 |
| Klucznik, RP | 1 |
| Clark, JM | 1 |
| McDougall, CG | 1 |
| Johnson, MD | 1 |
| Pride, GL | 1 |
| Lynch, JR | 1 |
| Zaidat, OO | 1 |
| Rumboldt, Z | 1 |
| Cloft, HJ | 1 |
| Nakagawa, I | 3 |
| Wada, T | 3 |
| Park, HS | 3 |
| Nishimura, F | 1 |
| Yamada, S | 2 |
| Nakagawa, H | 1 |
| Kichikawa, K | 3 |
| Nakase, H | 3 |
| Mansoor, AH | 1 |
| Mujtaba, MT | 1 |
| Silver, B | 1 |
| Alcocer, F | 1 |
| Novak, Z | 1 |
| Combs, BR | 1 |
| Lowman, B | 1 |
| Passman, MA | 1 |
| Mujib, M | 1 |
| Jordan, WD | 1 |
| Sakai, N | 1 |
| Yamagami, H | 1 |
| Matsubara, Y | 1 |
| Ezura, M | 1 |
| Hyodo, A | 1 |
| Matsumaru, Y | 1 |
| Miyachi, S | 1 |
| Okada, Y | 1 |
| Terada, T | 1 |
| Yokoi, H | 1 |
| Nakamura, M | 1 |
| Sakai, C | 1 |
| Ma, B | 1 |
| Hang, L | 1 |
| Chen, G | 1 |
| Du, Y | 1 |
| Yan, Y | 1 |
| Yuan, Y | 1 |
| Liang, L | 1 |
| Chen, T | 1 |
| Shen, Y | 1 |
| Zhong, C | 1 |
| Batchelder, A | 1 |
| Hunter, J | 1 |
| Cairns, V | 1 |
| Sandford, R | 1 |
| Munshi, A | 1 |
| Naylor, AR | 1 |
| Nishi, H | 1 |
| Nakahara, I | 1 |
| Matsumoto, S | 1 |
| Hashimoto, T | 1 |
| Ohta, T | 1 |
| Sadamasa, N | 1 |
| Ishibashi, R | 1 |
| Gomi, M | 1 |
| Saka, M | 1 |
| Miyata, H | 1 |
| Watanabe, S | 1 |
| Okata, T | 1 |
| Sonoda, K | 1 |
| Kouge, J | 1 |
| Ishii, A | 1 |
| Nagata, I | 1 |
| Kira, J | 1 |
| Cotsonis, GA | 1 |
| Jhang, KM | 1 |
| Huang, JY | 1 |
| Nfor, ON | 1 |
| Jian, ZH | 1 |
| Tung, YC | 1 |
| Ku, WY | 1 |
| Liaw, YP | 1 |
| Yokoyama, S | 2 |
| Hironaka, Y | 1 |
| Motoyama, Y | 2 |
| Takayama, K | 1 |
| Huibers, A | 1 |
| Halliday, A | 1 |
| Bulbulia, R | 1 |
| Coppi, G | 1 |
| de Borst, GJ | 1 |
| Gottschalksen, B | 1 |
| Hummel, T | 1 |
| Meves, SH | 2 |
| Rüdiger, K | 1 |
| Mügge, A | 1 |
| Mumme, A | 1 |
| Burkert, B | 1 |
| Mühlberger, D | 1 |
| Neubauer, H | 1 |
| Guo, J | 1 |
| Gu, Y | 1 |
| Guo, L | 1 |
| Yu, H | 1 |
| Qi, L | 1 |
| Tong, Z | 1 |
| Zhang, J | 1 |
| Wang, Z | 1 |
| Moon, K | 1 |
| Nanaszko, M | 1 |
| Levitt, MR | 1 |
| Gross, BA | 1 |
| Zabramski, JM | 1 |
| Spetzler, RF | 1 |
| Nakaji, P | 1 |
| Backovic, D | 1 |
| Ignjatovic, S | 1 |
| Rakicevic, L | 1 |
| Novkovic, M | 1 |
| Kusic-Tisma, J | 1 |
| Radojkovic, D | 1 |
| Strugarevic, E | 1 |
| Calija, B | 1 |
| Radak, D | 1 |
| Kovac, M | 1 |
| Deng, QQ | 1 |
| Tang, J | 1 |
| Chen, C | 2 |
| Markus, H | 1 |
| Huang, YN | 3 |
| Zhao, H | 1 |
| Ratanakorn, D | 2 |
| Wong, KS | 3 |
| Fu, JH | 1 |
| Oh, M | 1 |
| Lee, CW | 1 |
| Lee, HS | 1 |
| Chang, M | 1 |
| Ahn, JM | 1 |
| Park, DW | 1 |
| Kang, SJ | 1 |
| Lee, SW | 1 |
| Kim, YH | 1 |
| Moon, DH | 1 |
| Park, SW | 1 |
| Park, SJ | 1 |
| Illuminati, G | 1 |
| Schneider, F | 1 |
| Pizzardi, G | 1 |
| Masci, F | 1 |
| Calio', FG | 1 |
| Ricco, JB | 1 |
| Guerra, M | 1 |
| Mota, JC | 1 |
| Veloso, M | 1 |
| Gama, V | 1 |
| Vouga, L | 1 |
| Yamasaki, H | 1 |
| Matsubara, S | 2 |
| Sasaki, I | 1 |
| Nagahiro, S | 1 |
| Beckman, JA | 1 |
| Liu, F | 1 |
| Liu, JC | 1 |
| Wang, LJ | 1 |
| Li, J | 1 |
| Xu, XD | 1 |
| Liu, Y | 1 |
| Wang, DM | 1 |
| Yucel, S | 1 |
| Bahcivan, M | 1 |
| Gol, MK | 1 |
| Erenler, BH | 1 |
| Kolbakir, F | 1 |
| Keceligil, HT | 1 |
| Karkos, CD | 1 |
| Karamanos, DG | 1 |
| Papazoglou, KO | 1 |
| Demiropoulos, FP | 1 |
| Papadimitriou, DN | 1 |
| Gerassimidis, TS | 1 |
| Randall, MS | 2 |
| McKevitt, FM | 2 |
| Kumar, S | 1 |
| Cleveland, TJ | 2 |
| Endean, K | 1 |
| Venables, GS | 2 |
| Gaines, PA | 2 |
| Fu, J | 1 |
| Chang, HM | 1 |
| Suwanwela, NC | 1 |
| Han, Z | 1 |
| Tan, KS | 1 |
| Chollate, P | 1 |
| Zhao, Y | 1 |
| Koh, A | 1 |
| Hao, Q | 1 |
| Markus, HS | 3 |
| Polydorou, AD | 1 |
| Megaloikonomos, P | 1 |
| Moutiris, JA | 1 |
| Polydorou, V | 1 |
| Antypa, E | 1 |
| Testembasi, E | 1 |
| Tziakouri, CH | 1 |
| Palatianos, G | 1 |
| Nikas, D | 1 |
| Bolos, K | 1 |
| Polydorou, A | 1 |
| Hanna, EB | 1 |
| Abu-Fadel, MS | 1 |
| De Rango, P | 1 |
| Parlani, G | 1 |
| Romano, L | 1 |
| Verzini, F | 1 |
| Giordano, G | 1 |
| Cieri, E | 1 |
| Barbante, M | 1 |
| Cao, P | 1 |
| Ahn, CM | 1 |
| Hong, SJ | 1 |
| Park, JH | 1 |
| Kim, JS | 1 |
| Lim, DS | 1 |
| Farina, A | 1 |
| Spinazzola, A | 1 |
| Abbiati, G | 1 |
| Arpini, MT | 1 |
| Bergamaschi, L | 1 |
| Riva, A | 1 |
| Berticelli, P | 1 |
| Calabrò, RS | 1 |
| Pezzini, A | 1 |
| Gervasi, G | 1 |
| Pollicino, P | 1 |
| Bramanti, P | 1 |
| Leung, TW | 1 |
| Yu, SC | 1 |
| Profice, P | 1 |
| Pilato, F | 1 |
| Broccolini, A | 1 |
| Santoliquido, A | 1 |
| Della Marca, G | 1 |
| Di Lazzaro, V | 1 |
| Geisbüsch, P | 1 |
| Katzen, BT | 2 |
| Peña, C | 1 |
| Benenati, JF | 1 |
| Uthoff, H | 1 |
| Drazin, D | 1 |
| Choulakian, A | 1 |
| Nuño, M | 1 |
| Kornbluth, P | 1 |
| Alexander, MJ | 1 |
| Krings, T | 1 |
| Tsivgoulis, G | 1 |
| Kerasnoudis, A | 1 |
| Krogias, C | 1 |
| Vadikolias, K | 1 |
| Heliopoulos, I | 1 |
| Georgakarakos, E | 1 |
| Piperidou, C | 1 |
| Van Der Heyden, J | 1 |
| Van Werkum, J | 1 |
| Hackeng, CM | 1 |
| Kelder, JC | 1 |
| Breet, NJ | 1 |
| Deneer, VH | 1 |
| Ackerstaff, RG | 1 |
| Tromp, SC | 1 |
| De Vries, JP | 1 |
| Vos, JA | 1 |
| Suttorp, MJ | 1 |
| Elsenberg, EH | 1 |
| Van Neerven, D | 1 |
| Schonewille, WJ | 1 |
| Wolters, F | 1 |
| Ten Berg, JM | 1 |
| Carlson, AP | 1 |
| Alaraj, A | 1 |
| Amin-Hanjani, S | 1 |
| Charbel, FT | 1 |
| Aletich, VA | 1 |
| Andresen, R | 1 |
| Roth, M | 1 |
| Brinckmann, W | 1 |
| Barth, A | 1 |
| Zorger, N | 1 |
| Finkenzeller, T | 1 |
| Lenhart, M | 1 |
| Hamer, O | 1 |
| Paetzel, C | 1 |
| Borisch, I | 1 |
| Toepel, I | 1 |
| Feuerbach, S | 1 |
| Link, J | 1 |
| Andersohn, F | 1 |
| Hagmann, FG | 1 |
| Garbe, E | 1 |
| Schellinger, PD | 1 |
| Hacke, W | 2 |
| Tonarelli, SB | 1 |
| Hart, RG | 2 |
| Killestein, J | 1 |
| Sherif, C | 1 |
| Dick, P | 2 |
| Sabeti, S | 2 |
| Mlekusch, W | 2 |
| Amighi, J | 2 |
| Ahmadi, R | 1 |
| Lalouschek, W | 1 |
| Minar, E | 2 |
| Schillinger, M | 2 |
| Droste, DW | 3 |
| Kaps, M | 3 |
| Larrue, V | 2 |
| Lees, KR | 1 |
| Siebler, M | 2 |
| Ringelstein, EB | 2 |
| Tan, KT | 1 |
| Skvortsova, VI | 1 |
| Lemenev, VL | 1 |
| Akhmetov, VV | 1 |
| Alekseeva, GS | 1 |
| Stakhovskaia, LV | 1 |
| Gutsaliuk, AG | 1 |
| Larroche, C | 1 |
| Chadenat, ML | 1 |
| Chaunu, MP | 1 |
| Abad, S | 1 |
| Casassus, P | 1 |
| Dhôte, R | 1 |
| Ouriel, K | 1 |
| Wholey, MH | 1 |
| Fayad, P | 1 |
| Whitlow, P | 1 |
| Frentzko, M | 1 |
| Kuntz, RE | 1 |
| Wechsler, L | 1 |
| Hopkins, N | 1 |
| Satler, L | 1 |
| Mishkel, G | 1 |
| Yadav, JS | 4 |
| Boltuch, J | 1 |
| Schlager, O | 1 |
| Ahmadi, A | 1 |
| Imray, CH | 1 |
| Higman, DJ | 1 |
| Marshall, C | 1 |
| Cohen, SN | 1 |
| Hill, SL | 1 |
| Brozyna, W | 1 |
| Dittrich, R | 1 |
| Ritter, MA | 1 |
| Lees, K | 1 |
| Nabavi, DG | 1 |
| Defuentes, G | 1 |
| Lecoules, S | 1 |
| Vedrine, L | 1 |
| Coutant, G | 1 |
| Baranger, B | 1 |
| Algayres, JP | 1 |
| Buhk, JH | 1 |
| Wellmer, A | 1 |
| Knauth, M | 1 |
| Assadian, A | 1 |
| Eidher, U | 1 |
| Senekowitsch, C | 1 |
| Rotter, R | 1 |
| Löchli, S | 1 |
| Hagmüller, GW | 1 |
| Knöbl, P | 1 |
| Roffi, M | 2 |
| Onizuka, M | 1 |
| Nagata, S | 1 |
| Tomokiyo, M | 1 |
| Iko, M | 1 |
| Kodama, T | 1 |
| Tanaka, A | 1 |
| Kramer, J | 1 |
| Abraham, J | 1 |
| Teven, CM | 1 |
| Jones, PA | 1 |
| Topakian, R | 1 |
| Nussbaumer, K | 1 |
| Trenkler, J | 1 |
| Aichner, FT | 1 |
| Pyun, HW | 1 |
| Lee, DH | 1 |
| Kwon, SU | 1 |
| Lee, JH | 1 |
| Choi, CG | 1 |
| Kim, SJ | 1 |
| Suh, DC | 1 |
| Erdinler, IC | 1 |
| Ucer, E | 1 |
| Eksik, A | 1 |
| Akyol, A | 1 |
| Yazici, S | 1 |
| Iancu, A | 1 |
| Lazar, A | 1 |
| Diener, HC | 2 |
| Fehér, G | 1 |
| Bagoly, E | 1 |
| Kövér, F | 1 |
| Koltai, K | 1 |
| Hantó, K | 1 |
| Pozsgai, E | 1 |
| Komoly, S | 1 |
| Dóczi, T | 1 |
| Tóth, K | 1 |
| Szapáry, L | 1 |
| Ranucci, M | 1 |
| Nano, G | 1 |
| Pazzaglia, A | 1 |
| Bianchi, P | 1 |
| Casana, R | 1 |
| Tealdi, DG | 1 |
| Rothwell, PM | 1 |
| Rodin, IuV | 1 |
| Gao, L | 1 |
| Wang, PP | 1 |
| Liu, Q | 1 |
| Andreozzi, GM | 1 |
| Arosio, E | 1 |
| Martini, R | 1 |
| Verlato, F | 1 |
| Visonà, A | 1 |
| Kinoshita, A | 1 |
| Itoh, M | 1 |
| Takemoto, O | 1 |
| Fujimura, M | 1 |
| Mikashima, H | 1 |
| Sonne, M | 1 |
| Siemens, HJ | 1 |
| Benavente, O | 1 |
| Trivier, JM | 1 |
| Caron, J | 1 |
| Mahieu, M | 1 |
| Cambier, N | 1 |
| Rose, C | 1 |
| Mukherjee, D | 2 |
| Chew, DP | 2 |
| Robbins, M | 1 |
| Raymond, RE | 1 |
| Moliterno, DJ | 1 |
| Bhatt, DL | 1 |
| Kapadia, SR | 1 |
| Bajzer, CT | 1 |
| Ziada, KM | 1 |
| Topol, EJ | 1 |
| Wilterdink, JL | 1 |
| Easton, JD | 1 |
| Norris, JW | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy of Two Different Pre-Intervention Therapeutic Strategies With Clopidogrel and Atorvastatin for the Prevention of Cerebral Damage During Carotid Artery Stenting. Armyda-Caro Randomized Trial.[NCT01572623] | Phase 4 | 150 participants (Anticipated) | Interventional | 2011-07-31 | Recruiting | ||
| Stenting vs. Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis[NCT00576693] | Phase 3 | 451 participants (Actual) | Interventional | 2008-10-31 | Completed | ||
| Stroke Imaging Package Study of Intracranial Atherosclerosis[NCT03719820] | 550 participants (Anticipated) | Observational [Patient Registry] | 2018-11-14 | Recruiting | |||
| Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis- Magnetic Resonance Imaging[NCT05907629] | 300 participants (Anticipated) | Observational | 2023-12-30 | Not yet recruiting | |||
| Evolocumab Added to Statin Therapy in Patients With Symptomatic Intracranial Atherosclerotic Stenosis (EAST-ICAS)---a Pilot Study[NCT05741086] | Phase 3 | 80 participants (Anticipated) | Interventional | 2023-04-15 | Recruiting | ||
| China Angioplasty & Stenting for Symptomatic Intracranial Severe Stenosis (CASSISS): a New, Prospective, Multi-center, Randomized Controlled Trial in China[NCT01763320] | Phase 3 | 380 participants (Actual) | Interventional | 2014-03-05 | Completed | ||
| MULTIcentric Study About RESistance to CLOpidogrel in Dual Antiplatelet Therapy for Carotid Stenting[NCT05566301] | 1,140 participants (Anticipated) | Observational | 2021-09-02 | Recruiting | |||
| Carotid Stenosis Management During COVID-19 Era - Best Medical Intervention Alone (CASCOM Pilot Study): A Prospective Observational Study[NCT04947046] | 120 participants (Anticipated) | Observational | 2020-03-11 | Recruiting | |||
| Antiplatelet Therapy in Acute Mild-Moderate Ischemic Stroke (ATAMIS): a Parallel Randomized, Open-label, Multicenter, Prospective Study[NCT02869009] | Phase 3 | 3,000 participants (Actual) | Interventional | 2016-11-30 | Completed | ||
| Does the Magnitude of Platelet Inhibition Inversely Correlate With the Number of TCD-detected Microemboli in Asymptomatic Patients Undergoing Carotid Artery Stenting Prior to Cardiac Surgery Who Are Being Pre-treated With 300 mg or 600 mg Loading Dose of [NCT01146301] | Phase 4 | 0 participants | Interventional | 2008-03-31 | Completed | ||
| Revacept, an Inhibitor of Platelet Adhesion in Symptomatic Carotid Stenosis: A Phase II, Multicentre; Randomised, Dose-finding, Double-blind and Placebo Controlled Superiority Study With Parallel Groups[NCT01645306] | Phase 2 | 158 participants (Actual) | Interventional | 2013-03-08 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Any stroke (ischemic, parenchymal brain hemorrhage, subarachnoid or intraventricular hemorrhage) or death within 30 days after enrollment OR any stroke (ischemic, parenchymal brain hemorrhage, subarachnoid or intraventricular hemorrhage) or death within 30 days of any revascularization procedure of the qualifying symptomatic intracranial artery done during follow-up, OR an ischemic stroke in the territory of the symptomatic intracranial artery from day 31 after study entry to completion of follow-up. (NCT00576693)
Timeframe: Mean length of follow-up was 2.4 years
| Intervention | participants (Number) |
|---|---|
| Intensive Medical Management Plus Stenting | 52 |
| Intensive Medical Management Alone | 34 |
"Anti-drug antibodies were measured at baseline and 3 month after IMP application.~Number of patients with positive anti-drug antibodies compared to baseline are counted." (NCT01645306)
Timeframe: 3 month (+/- 1 month) after IMP application
| Intervention | Participants (Count of Participants) |
|---|---|
| Placebo | 0 |
| 40 mg Revacept | 0 |
| 120 mg Revacept | 0 |
patients with any stroke & TIA, myocardial infarction & percutaneous coronary intervention (PCI), death or bleeding within one year (365 days) after IMP application. (NCT01645306)
Timeframe: 365 days after IMP application
| Intervention | Number of Events (Number) |
|---|---|
| Placebo | 19 |
| 40 mg Revacept | 15 |
| 120 mg Revacept | 10 |
patients with major bleedings occuring within 90 days after IMP application (NCT01645306)
Timeframe: 90 days after IMP application
| Intervention | Participants (Count of Participants) |
|---|---|
| Placebo | 5 |
| 40 mg Revacept | 6 |
| 120 mg Revacept | 4 |
The number of new diffusion weighted imaging (DWI) lesion(s) reported. (1 day after intervention compared to baseline). (NCT01645306)
Timeframe: 1 day post intervention
| Intervention | Number of new lesions (Mean) |
|---|---|
| Placebo | 1.2 |
| 40 mg Revacept | 1.0 |
| 120 mg Revacept | 0.6 |
patients with any stroke or TIA occuring within 90 days after IMP application. (NCT01645306)
Timeframe: 90 days after IMP application
| Intervention | Participants (Count of Participants) |
|---|---|
| Placebo | 6 |
| 40 mg Revacept | 6 |
| 120 mg Revacept | 4 |
All adverse events were assessed during complete study period (~ 1 year after IMP application). (NCT01645306)
Timeframe: ~ 365 days after IMP application (whole study period)
| Intervention | participants (Number) | ||||
|---|---|---|---|---|---|
| patients with adverse events | patients with drug related AEs | patients with serious AEs | patients with drug related serious AEs | patients with AE with fatal outcome events | |
| 120 mg Revacept | 32 | 2 | 15 | 0 | 1 |
| 40 mg Revacept | 41 | 10 | 17 | 4 | 0 |
| Placebo | 35 | 4 | 17 | 1 | 0 |
10 reviews available for ticlopidine and Carotid Stenosis
| Article | Year |
|---|---|
The challenge of stroke prevention with intracranial arterial stenosis.
Topics: Aspirin; Carotid Artery, Common; Carotid Stenosis; Clopidogrel; Constriction, Pathologic; Drug Thera | 2013 |
Antiplatelet therapy to prevent recurrent stroke: Three good options.
Topics: Aspirin; Carotid Stenosis; Clopidogrel; Dipyridamole; Humans; Platelet Aggregation Inhibitors; Secon | 2013 |
Antithrombotic therapies in cerebrovascular disease: what should we use as secondary prevention in patients with carotid artery disease?
Topics: Anticoagulants; Aspirin; Brain Ischemia; Carotid Stenosis; Clopidogrel; Dipyridamole; Drug Therapy, | 2009 |
[Carotid stenosis: diagnosis, patient selection, therapy].
Topics: Aged; Aged, 80 and over; Angiography, Digital Subtraction; Angioplasty, Balloon; Aspirin; Carotid St | 2003 |
Stroke: advances in therapy.
Topics: Aspirin; Carotid Stenosis; Clinical Trials as Topic; Clopidogrel; Coronary Artery Bypass; Drug Thera | 2005 |
Extensive mobile thrombus of the internal carotid artery: a case report, treatment options, and a review of the literature.
Topics: Anticoagulants; Carotid Artery Thrombosis; Carotid Artery, Internal; Carotid Stenosis; Cerebral Angi | 2005 |
[What should be done after the first TIA?].
Topics: Angiotensin-Converting Enzyme Inhibitors; Aspirin; Carotid Artery, Internal; Carotid Stenosis; Clopi | 2007 |
Stroke: part I. A clinical update on prevention.
Topics: Aspirin; Atrial Fibrillation; Carotid Stenosis; Cerebrovascular Disorders; Clinical Trials as Topic; | 1999 |
Stroke prevention: antiplatelet and antithrombolytic therapy.
Topics: Anticoagulants; Aspirin; Brain Damage, Chronic; Carotid Stenosis; Clinical Trials as Topic; Clopidog | 2000 |
Outcome of transient ischaemic attacks and stroke.
Topics: Aged; Carotid Stenosis; Cerebrovascular Disorders; Humans; Ischemic Attack, Transient; Middle Aged; | 1991 |
21 trials available for ticlopidine and Carotid Stenosis
| Article | Year |
|---|---|
Strategies of clopidogrel load and atorvastatin reload to prevent ischemic cerebral events in patients undergoing protected carotid stenting. Results of the randomized ARMYDA-9 CAROTID (Clopidogrel and Atorvastatin Treatment During Carotid Artery Stenting
Topics: Aged; Angioplasty, Balloon; Anticholesteremic Agents; Atorvastatin; Brain Ischemia; Carotid Artery D | 2013 |
Cilostazol reduces periprocedural hemodynamic depression in carotid artery stenting.
Topics: Aged; Angioplasty; Bradycardia; Carotid Stenosis; Cilostazol; Clopidogrel; Female; Humans; Hypotensi | 2013 |
Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty; Aspirin; Carotid Stenosis; Clopidogrel; Female; Follow- | 2014 |
Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty; Aspirin; Carotid Stenosis; Clopidogrel; Female; Follow- | 2014 |
Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty; Aspirin; Carotid Stenosis; Clopidogrel; Female; Follow- | 2014 |
Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty; Aspirin; Carotid Stenosis; Clopidogrel; Female; Follow- | 2014 |
Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty; Aspirin; Carotid Stenosis; Clopidogrel; Female; Follow- | 2014 |
Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty; Aspirin; Carotid Stenosis; Clopidogrel; Female; Follow- | 2014 |
Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty; Aspirin; Carotid Stenosis; Clopidogrel; Female; Follow- | 2014 |
Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty; Aspirin; Carotid Stenosis; Clopidogrel; Female; Follow- | 2014 |
Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty; Aspirin; Carotid Stenosis; Clopidogrel; Female; Follow- | 2014 |
Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty; Aspirin; Carotid Stenosis; Clopidogrel; Female; Follow- | 2014 |
Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty; Aspirin; Carotid Stenosis; Clopidogrel; Female; Follow- | 2014 |
Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty; Aspirin; Carotid Stenosis; Clopidogrel; Female; Follow- | 2014 |
Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty; Aspirin; Carotid Stenosis; Clopidogrel; Female; Follow- | 2014 |
Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty; Aspirin; Carotid Stenosis; Clopidogrel; Female; Follow- | 2014 |
Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty; Aspirin; Carotid Stenosis; Clopidogrel; Female; Follow- | 2014 |
Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty; Aspirin; Carotid Stenosis; Clopidogrel; Female; Follow- | 2014 |
Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty; Aspirin; Carotid Stenosis; Clopidogrel; Female; Follow- | 2014 |
Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty; Aspirin; Carotid Stenosis; Clopidogrel; Female; Follow- | 2014 |
Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty; Aspirin; Carotid Stenosis; Clopidogrel; Female; Follow- | 2014 |
Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty; Aspirin; Carotid Stenosis; Clopidogrel; Female; Follow- | 2014 |
Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty; Aspirin; Carotid Stenosis; Clopidogrel; Female; Follow- | 2014 |
Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty; Aspirin; Carotid Stenosis; Clopidogrel; Female; Follow- | 2014 |
Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty; Aspirin; Carotid Stenosis; Clopidogrel; Female; Follow- | 2014 |
Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty; Aspirin; Carotid Stenosis; Clopidogrel; Female; Follow- | 2014 |
Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty; Aspirin; Carotid Stenosis; Clopidogrel; Female; Follow- | 2014 |
Effect of clopidogrel with or without omeprazole in patients with carotid artery stenting.
Topics: Angiography; Aspirin; Breath Tests; Carotid Arteries; Carotid Stenosis; Clopidogrel; Drug Interactio | 2013 |
Influence of carotid artery stenting on cognition of elderly patients with severe stenosis of the internal carotid artery.
Topics: Aged; Analysis of Variance; Angioplasty; Aspirin; Atorvastatin; Carotid Stenosis; China; Clopidogrel | 2014 |
Does the Stenting Versus Aggressive Medical Therapy Trial Support Stenting for Subgroups With Intracranial Stenosis?
Topics: Angioplasty; Aspirin; Carotid Artery, Internal; Carotid Stenosis; Clopidogrel; Constriction, Patholo | 2015 |
Antiplatelet Therapy in Carotid Artery Stenting and Carotid Endarterectomy in the Asymptomatic Carotid Surgery Trial-2.
Topics: Aspirin; Carotid Artery, Common; Carotid Stenosis; Clopidogrel; Dose-Response Relationship, Drug; En | 2016 |
[Prevalence of acetylsalicylic acid (ASA) - low response in vascular surgery].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Arterial Occlusive Diseases; Aspirin; Carotid Stenosi | 2016 |
Carotid Endarterectomy on Antiplatelet Agents in the Era of Point-of-Care Testing.
Topics: Aged; Arizona; Blood Loss, Surgical; Carotid Stenosis; Clopidogrel; Endarterectomy, Carotid; Female; | 2016 |
The curative effect comparison of two kinds of therapeutic regimens on decreasing the relative intensity of microembolic signal in CLAIR trial.
Topics: Aspirin; Brain Ischemia; Carotid Stenosis; Cerebral Arterial Diseases; Clopidogrel; Drug Therapy, Co | 2016 |
Similar Impact of Clopidogrel or Ticagrelor on Carotid Atherosclerotic Plaque Inflammation.
Topics: Adenosine; Aged; Anti-Inflammatory Agents; Carotid Arteries; Carotid Stenosis; Clopidogrel; Female; | 2016 |
Efficacy of cilostazol-based dual antiplatelet treatment in patients undergoing carotid artery stenting.
Topics: Aged; Aged, 80 and over; Aspirin; Carotid Stenosis; Cilostazol; Clopidogrel; Drug Therapy, Combinati | 2017 |
[Effect of different duration of clopidogrel pretreatment on platelet activation in patients undergoing stenting].
Topics: Adult; Aged; Aged, 80 and over; Carotid Stenosis; Clopidogrel; Female; Humans; Male; Middle Aged; Pl | 2009 |
Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial.
Topics: Adult; Aged; Aspirin; Carotid Artery, Internal; Carotid Stenosis; Clopidogrel; Drug Therapy, Combina | 2010 |
Cilostazol reduces the progression of carotid intima-media thickness without increasing the risk of bleeding in patients with acute coronary syndrome during a 2-year follow-up.
Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Analysis of Variance; Angioplasty, Balloon, Corona | 2011 |
High versus standard clopidogrel loading in patients undergoing carotid artery stenting prior to cardiac surgery to assess the number of microemboli detected with transcranial Doppler: results of the randomized IMPACT trial.
Topics: Aged; Cardiac Surgical Procedures; Carotid Stenosis; Clopidogrel; Dose-Response Relationship, Drug; | 2013 |
Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial.
Topics: Aged; Aspirin; Carotid Stenosis; Clopidogrel; Drug Monitoring; Drug Therapy, Combination; Embolism; | 2005 |
Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial.
Topics: Aged; Aspirin; Carotid Stenosis; Clopidogrel; Drug Monitoring; Drug Therapy, Combination; Embolism; | 2005 |
Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial.
Topics: Aged; Aspirin; Carotid Stenosis; Clopidogrel; Drug Monitoring; Drug Therapy, Combination; Embolism; | 2005 |
Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial.
Topics: Aged; Aspirin; Carotid Stenosis; Clopidogrel; Drug Monitoring; Drug Therapy, Combination; Embolism; | 2005 |
The benefits of combined anti-platelet treatment in carotid artery stenting.
Topics: Aged; Aged, 80 and over; Aspirin; Carotid Stenosis; Clopidogrel; Drug Therapy, Combination; Female; | 2005 |
[Local hemostasis during the carotid endarterectomy under condition of antithrombocytic therapy].
Topics: Aged; Aprotinin; Blood Coagulation; Blood Loss, Surgical; Blood Volume; Carotid Stenosis; Clopidogre | 2007 |
[Removing phlegm and dispelling stasis method combined with Western medicine for treatment of cerebrovascular stenosis].
Topics: Adult; Aged; Aspirin; C-Reactive Protein; Carotid Stenosis; Cerebrovascular Disorders; Clopidogrel; | 2008 |
Asymptomatic circulating cerebral emboli and cerebral blood flow velocity under aspirin and ticlopidine in patients with cerebrovascular disease.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Blood Flow Velocity; Carotid Stenosis; Cell Survival; Cereb | 1996 |
75 other studies available for ticlopidine and Carotid Stenosis
| Article | Year |
|---|---|
High-on-treatment platelet reactivity predicts adverse outcome after carotid artery stenting: A prospective study.
Topics: Aspirin; Blood Platelets; Carotid Arteries; Carotid Stenosis; Humans; Percutaneous Coronary Interven | 2023 |
Natural history of antiplatelet nonresponders undergoing carotid artery stenting.
Topics: Carotid Arteries; Carotid Stenosis; Clopidogrel; Humans; Prospective Studies; Stents; Thromboembolis | 2023 |
Impact of continued clopidogrel use on outcomes of patients undergoing carotid endarterectomy.
Topics: Aged; Aspirin; Carotid Stenosis; Clopidogrel; Endarterectomy, Carotid; Female; Humans; Male; Myocard | 2023 |
The Feasibility and Safety of Separate Carotid Artery Stenting Using the Restrict Protective Method for Bilateral Carotid Stenosis.
Topics: Adult; Aged; Aged, 80 and over; Angiography, Digital Subtraction; Carotid Arteries; Carotid Stenosis | 2017 |
Assessment of 'on-treatment platelet reactivity' and relationship with cerebral micro-embolic signals in asymptomatic and symptomatic carotid stenosis.
Topics: Aged; Aspirin; Brain; Carotid Stenosis; Case-Control Studies; Clopidogrel; Disease Progression; Fema | 2017 |
Medical Therapy Before Carotid Endarterectomy: Changes Over a 13-Year Period and Comparison Between Asymptomatic and Symptomatic Patients.
Topics: Aged; Aged, 80 and over; Carotid Stenosis; Endarterectomy, Carotid; Female; Humans; Male; Middle Age | 2018 |
Clopidogrel Load Reduces Emboli in Carotid Artery Stenosis With Free-Floating Thrombus.
Topics: Carotid Artery, Internal; Carotid Stenosis; Clopidogrel; Embolism; Humans; Magnetic Resonance Imagin | 2017 |
Carotid Endarterectomy and Concurrent Clopidogrel Use: National Practice Patterns in the United States.
Topics: Aged; Carotid Stenosis; Clopidogrel; Combined Modality Therapy; Databases, Factual; Endarterectomy, | 2018 |
Urgent best medical therapy may obviate the need for urgent surgery in patients with symptomatic carotid stenosis.
Topics: Adult; Ambulatory Care; Carotid Stenosis; Clopidogrel; Disease Management; Drug Therapy, Combination | 2013 |
Carotid artery stenting outcomes: do they correlate with antiplatelet response assays?
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Brain Ischemia; Carotid Stenosis; Cerebral Revascularizatio | 2014 |
Efficacy of contemporary medical management for asymptomatic carotid artery stenosis.
Topics: Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; | 2013 |
Platelet inhibition by adjunctive cilostazol suppresses the frequency of cerebral ischemic lesions after carotid artery stenting in patients with carotid artery stenosis.
Topics: Aged; Angioplasty; Aspirin; Brain Ischemia; Carotid Stenosis; Cilostazol; Clopidogrel; Diffusion Mag | 2014 |
Dual antiplatelet therapy (clopidogrel and aspirin) is associated with increased all-cause mortality after carotid revascularization for asymptomatic carotid disease.
Topics: Aged; Alabama; Angioplasty; Aspirin; Asymptomatic Diseases; Carotid Stenosis; Clopidogrel; Drug Ther | 2014 |
Prospective registry of carotid artery stenting in Japan--investigation on device and antiplatelet for carotid artery stenting.
Topics: Aged; Aged, 80 and over; Aspirin; Carotid Arteries; Carotid Stenosis; Cilostazol; Clopidogrel; Drug | 2014 |
Dual Antiplatelet Therapy Prior to Expedited Carotid Surgery Reduces Recurrent Events Prior to Surgery without Significantly Increasing Peri-operative Bleeding Complications.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Blood Loss, Surgical; Carotid Stenosis; Clopidogrel; Drug A | 2015 |
Platelet reactivity and hemorrhage risk in neurointerventional procedures under dual antiplatelet therapy.
Topics: Aged; Aspirin; Carotid Stenosis; Clopidogrel; Drug Therapy, Combination; Embolization, Therapeutic; | 2016 |
Is Extended Duration of Dual Antiplatelet Therapy After Carotid Stenting Beneficial?
Topics: Aged; Aspirin; Carotid Arteries; Carotid Stenosis; Clopidogrel; Female; Follow-Up Studies; Humans; M | 2015 |
Influence of Diabetes Mellitus and Cigarette Smoking on Variability of the Clopidogrel-Induced Antiplatelet Effect and Efficacy of Active Management of the Target P2Y12 Reaction Unit Range in Patients Undergoing Neurointerventional Procedures.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Aspirin; Carotid Stenosis; Cilostazol; Clopidogrel; Dia | 2016 |
Risk of early recurrent stroke in symptomatic carotid stenosis after best medical therapy and before endarterectomy.
Topics: Aged; Aged, 80 and over; Aspirin; Carotid Arteries; Carotid Stenosis; Clopidogrel; Endarterectomy, C | 2016 |
Effects of Sarpogrelate Combined with Aspirin in Patients Undergoing Carotid Endarterectomy in China: A Single-Center Retrospective Study.
Topics: Aged; Aspirin; Blood Loss, Surgical; Carotid Stenosis; China; Clopidogrel; Drug Therapy, Combination | 2016 |
Clopidogrel High On-Treatment Platelet Reactivity in Patients with Carotid Artery Stenosis Undergoing Endarterectomy. A Pilot Study.
Topics: Aged; Carotid Stenosis; Chi-Square Distribution; Clopidogrel; Cytochrome P-450 CYP2C19; Drug Resista | 2016 |
Dual Antiplatelet Therapy Does Not Increase the Risk of Bleeding After Carotid Endarterectomy: Results of a Prospective Study.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Asymptomatic Diseases; Carotid Stenosis; Clopidogr | 2017 |
Combined carotid stenting and urgent coronary artery surgery in unstable angina patients with severe carotid stenosis.
Topics: Aged; Aged, 80 and over; Angina, Unstable; Angioplasty, Balloon; Anticoagulants; Aspirin; Carotid St | 2009 |
Retinal artery embolization during carotid angioplasty and carotid artery stenting: case report.
Topics: Aged; Angioplasty, Balloon; Anticoagulants; Antipyrine; Aspirin; Carotid Artery, External; Carotid S | 2009 |
Reduced intimal hyperplasia in rabbits via medical therapy after carotid venous bypass.
Topics: Administration, Oral; Animals; Atorvastatin; Benzopyrans; Calcium Dobesilate; Cardiovascular Agents; | 2009 |
Thirty-day outcome following carotid artery stenting: a 10-year experience from a single center.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Angiography; Carotid Stenosis; Clopidogrel; Co | 2010 |
Long-term results of carotid artery stents to manage symptomatic carotid artery stenosis and factors that affect outcome.
Topics: Adult; Aged; Aged, 80 and over; Blood Vessel Prosthesis Implantation; Carotid Stenosis; Chemotherapy | 2010 |
Carotid angioplasty in asymptomatic patients undergoing CABG surgery.
Topics: Aged; Angioplasty, Balloon; Anticoagulants; Carotid Stenosis; Clopidogrel; Coronary Angiography; Cor | 2010 |
Management of severe bilateral carotid artery stenosis concomitant to severely symptomatic coronary arterial disease requiring coronary artery bypass grafting: a case-based review.
Topics: Carotid Artery Diseases; Carotid Stenosis; Clopidogrel; Coronary Artery Bypass; Endarterectomy, Caro | 2010 |
Second-generation thienopyridine use is not associated with better early perioperative outcome during carotid stenting.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Angioplasty; Asymptomatic Diseases; Carotid Stenosis; | 2011 |
[Beyond coronary artery disease: interventional approach to carotid occlusive disease].
Topics: Aged; Aged, 80 and over; Angioplasty; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Carotid Arte | 2010 |
Recurrent ischemic stroke in a patient with ulcerative colitis and high levels of lipoprotein (a).
Topics: Anticholesteremic Agents; Anticoagulants; Aspirin; Atorvastatin; Blood Coagulation Tests; Carotid St | 2011 |
Have medical therapy and stenting been fairly compared? A repercussion upon termination of recruitment in the SAMMPRIS trial.
Topics: Angioplasty; Aspirin; Carotid Stenosis; Clinical Trials as Topic; Clopidogrel; Humans; National Inst | 2011 |
Right hemiparesis in right carotid stenosis.
Topics: Aged; Anticholesteremic Agents; Atherectomy; Atorvastatin; Carotid Stenosis; Clopidogrel; Combined M | 2011 |
Bivalirudin used as alternative anticoagulant in carotid artery stenting: a single center observational study.
Topics: Adult; Aged; Aged, 80 and over; Antithrombins; Carotid Stenosis; Clopidogrel; Female; Hirudins; Huma | 2012 |
Body weight: a risk factor for subtherapeutic antithrombotic therapy in neurovascular stenting.
Topics: Aspirin; Body Mass Index; Body Weight; Carotid Stenosis; Cerebrovascular Disorders; Clopidogrel; Fem | 2011 |
Editorial - do not throw the baby out with the bathwater….
Topics: Angioplasty; Aspirin; Carotid Stenosis; Clopidogrel; Humans; Multicenter Studies as Topic; National | 2011 |
Clopidogrel load for emboli reduction in patients with symptomatic carotid stenosis undergoing urgent carotid endarterectomy.
Topics: Aged; Carotid Stenosis; Clopidogrel; Emergency Treatment; Endarterectomy, Carotid; Female; Humans; I | 2012 |
Continued concern about parent vessel steno-occlusive progression with Onyx HD-500 and the utility of quantitative magnetic resonance imaging in serial assessment.
Topics: Angioplasty; Aspirin; Carotid Artery Diseases; Carotid Stenosis; Clopidogrel; Constriction, Patholog | 2013 |
[Outpatient primary stent-angioplasty in symptomatic internal carotid artery stenoses].
Topics: Aged; Angiography; Angioplasty, Balloon; Anticoagulants; Aspirin; Carotid Artery, Internal; Carotid | 2003 |
Safety and efficacy of the Perclose suture-mediated closure device following carotid artery stenting under clopidogrel platelet blockade.
Topics: Aged; Angioplasty; Carotid Artery, Internal; Carotid Stenosis; Clopidogrel; Female; Femoral Artery; | 2004 |
Thrombotic thrombocytopenic purpura/haemolytic uraemic syndrome associated with clopidogrel: report of two new cases.
Topics: Adult; Aged; Angina Pectoris; Carotid Artery, Internal; Carotid Stenosis; Clopidogrel; Hemolytic-Ure | 2004 |
Carotid-artery stenting versus endarterectomy.
Topics: Angioplasty, Balloon; Carotid Stenosis; Clopidogrel; Combined Modality Therapy; Endarterectomy, Caro | 2005 |
Carotid-artery stenting versus endarterectomy.
Topics: Angioplasty, Balloon; Carotid Stenosis; Clopidogrel; Combined Modality Therapy; Endarterectomy, Caro | 2005 |
Neurological outcome of conservative versus endovascular treatment of patients with asymptomatic high-grade carotid artery stenosis: a propensity score-adjusted analysis.
Topics: Aged; Angioplasty; Aspirin; Carotid Stenosis; Clopidogrel; Disease-Free Survival; Female; Follow-Up | 2005 |
[The efficacy of surgical and conservative methods in secondary prevention of carotid ischemic stroke].
Topics: Aged; Brain; Brain Ischemia; Carotid Stenosis; Cerebral Arteries; Clopidogrel; Combined Modality The | 2005 |
[Strokes associated with cervical artery dissection, and systemic mastocytosis: an unfortuitous association? A report of two cases].
Topics: Aspirin; Brain Infarction; Carotid Artery, Internal, Dissection; Carotid Stenosis; Clopidogrel; Fibr | 2005 |
[Prophylaxis of stroke].
Topics: Age Factors; Aged; Angioplasty, Balloon; Anticoagulants; Antihypertensive Agents; Aspirin; Atrial Fi | 2005 |
Feasibility trial of carotid stenting with and without an embolus protection device.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Blood Vessel Prosthesis Implantation; Carotid Artery, Commo | 2005 |
Procedure-related complications and early neurological adverse events of unprotected and protected carotid stenting: temporal trends in a consecutive patient series.
Topics: Aged; Aspirin; Blood Vessel Prosthesis Implantation; Carotid Artery, Internal; Carotid Stenosis; Clo | 2005 |
Letter regarding article by Markus et al, "Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic cardiac stenosis evaluated using doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid
Topics: Aspirin; Carotid Stenosis; Clopidogrel; Drug Therapy, Combination; Embolism; Humans; Platelet Aggreg | 2005 |
Letter regarding article by Markus et al, "Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic cardiac stenosis evaluated using doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid
Topics: Aspirin; Carotid Stenosis; Clopidogrel; Drug Therapy, Combination; Embolism; Humans; Platelet Aggreg | 2005 |
The use of embolic signal detection in multicenter trials to evaluate antiplatelet efficacy: signal analysis and quality control mechanisms in the CARESS (Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic carotid Stenosis) trial.
Topics: Aspirin; Carotid Stenosis; Clopidogrel; Humans; Intracranial Embolism; Multicenter Studies as Topic; | 2006 |
[Accelerated atheroma with prednisone and clopidogrel].
Topics: Aged; Atherosclerosis; Carotid Stenosis; Clopidogrel; Endarterectomy; Giant Cell Arteritis; Glucocor | 2006 |
Late in-stent thrombosis following carotid angioplasty and stenting.
Topics: Aged; Aged, 80 and over; Angiography, Digital Subtraction; Angioplasty, Balloon; Anticoagulants; Aph | 2006 |
Antiplatelet therapy prior to carotid endarterectomy--still room for improvement.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Austria; Carotid Artery, Internal; Carotid Stenosis; Clopid | 2006 |
Carotid stenting.
Topics: Aged; Aspirin; Cardiovascular Agents; Carotid Artery, Internal; Carotid Stenosis; Clopidogrel; Endar | 2006 |
The significance of incomplete stent apposition in patients undergoing stenting of internal carotid artery stenosis.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon; Aspirin; Brain Ischemia; Carotid Arteries; Carotid St | 2006 |
Role of antiplatelets in carotid artery stenting.
Topics: Angioplasty, Balloon; Aspirin; Carotid Stenosis; Clinical Trials as Topic; Clopidogrel; Dipyridamole | 2007 |
Late in-stent thrombosis following carotid angioplasty and stenting.
Topics: Aged; Aged, 80 and over; Angiography, Digital Subtraction; Angioplasty, Balloon; Anticoagulants; Aph | 2007 |
Internal carotid artery stenosis with ipsilateral persistent hypoglossal artery presenting as a multiterritorial embolic infarction: a case report.
Topics: Aged; Aspirin; Basilar Artery; Brain; Carotid Artery, Internal; Carotid Stenosis; Cerebral Infarctio | 2007 |
Noncardiogenic pulmonary edema associated with clopidogrel: a serious but unexpected side effect of clopidogrel.
Topics: Aged; Angioplasty; Blood Chemical Analysis; Carotid Stenosis; Clopidogrel; Diagnosis, Differential; | 2007 |
Carotid artery in-stent restenosis in a patient with contralateral total occlusion, resolved with drug-eluting stenting.
Topics: Aged; Angioplasty, Balloon; Carotid Arteries; Carotid Artery Thrombosis; Carotid Stenosis; Catheteri | 2007 |
[The effect of carotid stenting on rheological parameters, free radical production and platelet aggregation].
Topics: Aged; Carotid Stenosis; Clopidogrel; Female; Fibrinogen; Follow-Up Studies; Free Radicals; Hematocri | 2007 |
Platelet mapping and desmopressin reversal of platelet inhibition during emergency carotid endarterectomy.
Topics: Blood Platelets; Carotid Stenosis; Clopidogrel; Deamino Arginine Vasopressin; Emergencies; Endartere | 2007 |
Prediction and prevention of stroke in patients with symptomatic carotid stenosis: the high-risk period and the high-risk patient.
Topics: Aspirin; Carotid Stenosis; Clopidogrel; Endarterectomy, Carotid; Humans; Ischemic Attack, Transient; | 2008 |
Consensus document on intermittent claudication from the Central European Vascular Forum 1st edition - Abano Terme (Italy) - May 2005 2nd revision - Portroz (Slovenia) September 2007.
Topics: Aspirin; Carotid Stenosis; Clopidogrel; Disease Progression; Exercise Test; Humans; Intermittent Cla | 2008 |
Percutaneous transluminal angioplasty of internal carotid artery: a preliminary report of seesaw balloon technique.
Topics: Angioplasty, Balloon; Carotid Artery, Internal; Carotid Stenosis; Combined Modality Therapy; Heparin | 1993 |
Effect of Y-20811, a thromboxane synthetase inhibitor, on photochemically induced cerebral embolism in rabbits.
Topics: Animals; Aspirin; Carotid Artery Thrombosis; Carotid Stenosis; Cerebral Infarction; Disease Models, | 1993 |
[Prevention and therapy of stroke].
Topics: Carotid Stenosis; Cerebrovascular Disorders; Humans; Platelet Aggregation Inhibitors; Ticlopidine | 1994 |
Antiplatelet drugs in cardiovascular prevention: coronary events and stroke: primary prevention.
Topics: Aspirin; Carotid Stenosis; Cost-Benefit Analysis; Diabetes Mellitus; Digestive System; Female; Human | 2000 |
Fatal aplastic anaemia associated with clopidogrel.
Topics: Aged; Aged, 80 and over; Anemia, Aplastic; Carotid Stenosis; Clopidogrel; Humans; Male; Platelet Agg | 2001 |
Clinical application of procedural platelet monitoring during percutaneous coronary intervention among patients at increased bleeding risk.
Topics: Abciximab; Adult; Aged; Aged, 80 and over; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibod | 2001 |
Dual antiplatelet therapy with clopidogrel and aspirin after carotid artery stenting.
Topics: Aged; Aged, 80 and over; Aspirin; Carotid Stenosis; Clopidogrel; Combined Modality Therapy; Female; | 2001 |
Vascular event rates in patients with atherosclerotic cerebrovascular disease.
Topics: Age Factors; Aged; Carotid Stenosis; Cerebrovascular Disorders; Epidemiologic Methods; Humans; Intra | 1992 |